NephroPlus, Dominant dialysis network, has added Dr. Om Prakash Manchanda to the Board of Directors as an Independent Director. This induction will help NephroPlus in its scale-up journey as it expands in domestic and international markets.
Dr. Om Prakash Manchanda is the Managing Director of Dr Lal PathLabs, a medical diagnostics company. Dr. Om Prakash Manchanda has helped transform Dr Lal PathLabs into its current network of over 200 labs, more than 2,500 patient service centers, and close to 6,500 sample pick-up-points.
Before joining Dr Lal PathLabs in 2005, Dr. Om Prakash Manchanda led the International & Innovation group of the Consumer Healthcare Division at Ranbaxy. Prior to Ranbaxy, he worked for Monsanto as the head of Sales and Marketing, where his team launched the company’s first ever biotech product Bt-Cotton.
Earlier, during his tenure with Hindustan Unilever for about 10 years, he received exposure in consumer product sales, distribution and marketing. An MBA from the Indian Institute of Management, Ahmedabad, Dr. Om Prakash Manchanda is also a Doctor in Veterinary Sciences from HAU, Hisar.
Speaking on this occasion, Mr, Vikram Vuppala, Founder and CEO, NephroPlus said, “We are delighted to welcome Dr. Om Prakash Manchanda to the Board of Directors at NephroPlus. He is one of the very few leaders in the healthcare industry who has successfully scaled up a distributed network into a multi-billion dollar listed enterprise. He is exceptionally well-regarded in the healthcare industry and we are sure he will add a strong independent voice in our Board discussions related to our future expansion plans in India and the overseas markets. I am personally looking forward to working with him as we embark on our next phase of growth!”
Speaking on the new role Dr. Om Prakash Manchanda said, “I have been tracking NephroPlus for several years now and have watched the company grow in India and recently in the overseas markets as well. What excites me the most about NephroPlus is its patient centricity, which is very crucial in healthcare systems. The current dominant leadership position in India and the thoughtful approach with which the Company is pursuing International markets are quite compelling success factors. I look forward to supporting NephroPlus in the next phase of its scale-up journey in India and beyond.”
Arya has been a part of the Content & Research Team at Hrnxt.com. She is a keen observer of economic developments, emerging businesses, people in business and keeps a tab on latest happenings in the business environment.